Feedback / Questions
Proellex (telapristone oral) - Repros
Proellex: Patent protection related to NCE until 2021
(Repros)
-
Aug 10, 2017 -
Corporate Presentation
Patent
•
Endometriosis • Uterine Leiomyoma • Women's Health
http://reprosrx.com/documents/2017_August_RPRX_Talking_Points.pdf
Aug 10, 2017
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious